IDEXX LABORATORIES INC /DE Repayments of Senior Debt
IDEXX LABORATORIES INC /DE (IDXX) reported Repayments of Senior Debt of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSeniorDebt · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE repayments of senior debt for the quarter ending 2025-12-31 was $75.00M.
- IDEXX LABORATORIES INC /DE repayments of senior debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE repayments of senior debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE repayments of senior debt for the quarter ending 2024-09-30 was $75.00M.
- IDEXX LABORATORIES INC /DE repayments of senior debt for fiscal 2025 was $178.38M, a 137.85% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE repayments of senior debt for fiscal 2024 was $75.00M, a 0.00% change from fiscal 2023.
- IDEXX LABORATORIES INC /DE repayments of senior debt for fiscal 2023 was $75.00M, a 0.00% change from fiscal 2022.
- IDEXX LABORATORIES INC /DE repayments of senior debt for fiscal 2022 was $75.00M, a 50.00% increase from fiscal 2021.
| Period end | Repayments of Senior Debt 3 month | Repayments of Senior Debt 6 month | Repayments of Senior Debt 9 month | Repayments of Senior Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $75.00M derived: sum of 2 quarters · filed 2026-02-20 | $178.38M 10-K · filed 2026-02-20 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $103.39M 10-Q · filed 2025-11-03 | ||
| 2025-06-30 | $103.39M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $75.00M derived: sum of 2 quarters · filed 2026-02-20 | $75.00M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $75.00M 10-Q · filed 2025-11-03 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-04 | |||
| 2023-12-31 | $75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $75.00M derived: sum of 2 quarters · filed 2026-02-20 | $75.00M derived: sum of 3 quarters · filed 2026-02-20 | $75.00M 10-K · filed 2026-02-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $0.00 10-Q · filed 2023-08-01 | $0.00 derived: sum of 3 quarters · filed 2025-02-21 | $0.00 derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-02-21 | $0.00 derived: sum of 3 quarters · filed 2025-02-21 | $0.00 derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $0.00 derived: sum of 2 quarters · filed 2025-02-21 | $0.00 derived: sum of 3 quarters · filed 2025-02-21 | $75.00M 10-K · filed 2025-02-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $75.00M 10-Q · filed 2023-11-01 | $75.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $75.00M 10-Q · filed 2023-08-01 | $75.00M derived: sum of 3 quarters · filed 2024-02-22 | $125.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $75.00M 10-Q · filed 2023-05-02 | $75.00M derived: sum of 2 quarters · filed 2024-02-22 | $125.00M derived: sum of 3 quarters · filed 2024-02-22 | $125.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $50.00M derived: sum of 2 quarters · filed 2024-02-22 | $50.00M derived: sum of 3 quarters · filed 2024-02-22 | $50.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $50.00M derived: sum of 2 quarters · filed 2022-11-01 | $50.00M 10-Q · filed 2022-11-01 | $50.00M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | $0.00 derived: sum of 3 quarters · filed 2023-02-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-02-16 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $0.00 10-K · filed 2023-02-16 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |